Global AT2R-targeted drug development remains nascent, with only a few competitors like Lilly-partnered CFTX-1554 (Phase I).

In parallel with these encouraging results, Tiziana Life Sciences has initiated a randomized, double-blind, placebo-controlled Phase 2 clinical trial to further assess the efficacy and safety of nasal ...

Learn about eye changes that could indicate serious health conditions, from blurry vision to persistent floaters and flashes ...

Research suggests that better understanding the psychological and neurological components of chronic pain may lead to better ...